...
首页> 外文期刊>Rapid Communications in Mass Spectrometry: RCM >Expanding sports drug testing assays: Mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105
【24h】

Expanding sports drug testing assays: Mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105

机译:扩展的运动药物测试测定:选择性雄激素受体调节剂候选药物RAD140和ACP-105的质谱表征

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

RATIONALE Anabolic agents have been top-ranked for many years among statistics of adverse analytical findings compiled by the World Anti-Doping Agency (WADA). Besides archetypical anabolic-androgenic steroids (AAS), alternative substances with similar effects concerning bone and muscle anabolism have been therapeutically pursued. A prominent emerging class of drugs is the chemically heterogeneous group of selective androgen receptor modulators (SARMs), some of which have been detected in doping control samples between 2009 and 2012 despite missing clinical approval. METHODS In order to support the momentum of expanding the preventive and proactive measures among anti-doping laboratories, the analytical characterization of substances with misuse potential is of great importance. In the present study, the SARM drug candidates RAD140 (comprising a 5-phenyloxadiazole nucleus) and ACP-105 (bearing an N-substituted tropanol pharmacophore) were studied regarding their mass spectrometric behavior under ESI-MS(/MS) and EI-MS(/MS) conditions. Reference material was synthesized according to established protocols and dissociation pathways of RAD140 and ACP-105 were elucidated with liquid chromatography/ electrospray ionization quadrupole/time-of-flight or iontrap/orbitrap and gas chromatography/electron ionization quadrupole/time-of-flight high resolution/high accuracy mass spectrometry. RESULTS Fragmentation pathways to diagnostic product ions of RAD140 (e.g. m/z 223 and 205 using ESI-MS/MS and m/z 421 and 349 using EI-MS/MS) and ACP-105 (such as m/z 233 and 193 or 231 and 217 for ESI-MS/MS and EI-MS/MS measurements, respectively) were proposed as substantiated by determined elemental compositions and MS~n experiments as well as comparison to spectra of a structural analog. Notably, for the formation of the characteristic fragment ion at m/z 421 of RAD140, the comparably seldom intramolecular migration of a trimethylsilyl residue triggered by electron ionization was suggested as corroborated by all of the above-mentioned analytical means. CONCLUSIONS The obtained data will support future sports drug testing methods and facilitate and accelerate the implementation of this analyte and related compounds or metabolites in both GC/MS(/MS)- and LC/MS(/MS)-based routine doping control procedures.
机译:理由多年来,由世界反兴奋剂机构(WADA)编制的不利分析结果统计中,合成代谢药物一直位居第一。除了典型的合成代谢雄激素类固醇(AAS)外,在治疗上还寻求了对骨骼和肌肉合成代谢具有类似作用的替代物质。新兴的一类突出的药物是化学异质性的选择性雄激素受体调节剂(SARMs)组,尽管缺少临床批准,但在2009年至2012年间的兴奋剂对照样品中已检测到其中的一些。方法为了支持在反兴奋剂实验室中扩大预防和积极措施的势头,对具有滥用潜力的物质进行分析表征非常重要。在本研究中,研究了SARM候选药物RAD140(包含5-苯基恶二唑核)和ACP-105(带有N-取代的对羟基苯酚药效基团)在ESI-MS(/ MS)和EI-MS下的质谱行为(/ MS)条件。根据建立的方案合成参考物质,并通过液相色谱/电喷雾电离四极杆/飞行时间或离子阱/轨道飞行器和气相色谱/电子电离四极杆/飞行时间高的方法阐明RAD140和ACP-105的解离途径分辨率/高精度质谱。结果RAD140诊断产物离子(例如,使用ESI-MS / MS的m / z 223和205和使用EI-MS / MS的m / z 421和349)和ACP-105(例如m / z 233和193)的碎片化途径提议分别用ESI-MS / MS和EI-MS / MS分别测定231或217)作为确定的元素组成和MS〜n实验以及与结构类似物光谱的比较。值得注意的是,对于在RAD140的m / z 421处形成特征性碎片离子而言,建议通过所有上述分析手段来证实由电子电离引发的三甲基甲硅烷基残基的相对较少的分子内迁移。结论所获得的数据将支持未来的运动药物测试方法,并在基于GC / MS(/ MS)和LC / MS(/ MS)的常规掺杂控制程序中促进并加速该分析物及相关化合物或代谢物的实施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号